Search clinical trials for: OPC-41061

Total 912 results

Otsuka Pharmaceutical Co., Ltd.

Completed

Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake

Congestive Heart Failure

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease

Crohn's Disease

Korea, Republic of, Japan
Otsuka Pharmaceutical Co., Ltd.

Terminated

A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease

Crohn Disease

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia

Schizophrenia

Japan
Dorothy Kessler

Completed

Creating Satisfying Engagement in Daily Life Through Coaching for People With Multiple Sclerosis

Quality of Life | Multiple Sclerosis

Canada
Otsuka Pharmaceutical Co., Ltd.

Completed

To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease

China, Japan, Korea, Republic of
Ottawa Hospital Research Institute
University of Ottawa

Completed

Occupational Performance Coaching for Stroke Survivors

Stroke

Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Ulcerative Colitis

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Ulcerative Colitis

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial of OPC-64005 for Major Depressive Disorder

Major Depressive Disorder

Japan
Wake Forest University Health Sciences

Completed

Flavonoid Supplementation and Endothelial Function

Healthy
Otsuka Frankfurt Research Institute GmbH

Completed

Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa
Otsuka Pharmaceutical Co., Ltd.

Completed

Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

Congestive Heart Failure

Japan
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Tuberculosis, Multidrug-Resistant

Korea, Republic of, China, Estonia, Latvia, Peru, Philippines
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation (CADENCE 215)

Atrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation

United States, Italy, Germany, Netherlands, Spain, United Kingdom
The Hong Kong Polytechnic University
University of Otago; Food and Health Bureau, Hong Kong; National Cheng Kung University

Recruiting

Occupational Performance Coaching With Parents of Young Children With Developmental Disability

Developmental Disability

Hong Kong
Otsuka Pharmaceutical Co., Ltd.

Completed

Dose-response Study of OPC-12759 Ophthalmic Suspension

Dry Eye Syndromes

Japan
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis

Tuberculosis

Latvia, Lithuania
Axonics, Inc.

Recruiting

F15 Recharge Free Axonics SNM System Clinical Study

Urinary Urge Incontinence (UUI) | Fecal Incontinence (FI) | Urinary Frequency (UF)

Netherlands, United States
Otsuka Pharmaceutical Development & Commercialization...
Bill and Melinda Gates Foundation

Active, not recruiting

Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB

Pulmonary TB

South Africa
Tomsk National Research Medical Center of the Russian...

Completed

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2.

Breast Cancer Female

Russian Federation
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia (VECTOR)

Acute Schizophrenia

Korea, Republic of, United States, Serbia, Ukraine, Romania, Poland, Canada, Latvia, Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)

Atrial Fibrillation

Japan
Centre for Probe Development and Commercialization

Completed

A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours

Cancer

Canada
Medical University of South Carolina

Terminated

AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy

Breast Cancer

United States
University of Kansas Medical Center

Completed

Telehealth Coaching for Families of Children With Autism

Autism Spectrum Disorders

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial) (Pyxis)

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, France, Poland, Canada, Slovakia
Odense University Hospital

Terminated

Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Rectal Cancer | Ulcerative Colitis | Short Bowel Syndrome

Denmark
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) (Polaris)

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, Russian Federation, Hungary, Romania, Ukraine, Canada, Germany
Brigham Young University

Recruiting

Heart Rate Variability Biofeedback Following Traumatic Brain Injury

Traumatic Brain Injury

United States
Centre Hospitalier Universitaire de Nice

Completed

Preformed Pediatric Crown Zirconia Versus Preformed Pediatric Metal Crown (PPC Z-M)

Tooth Decay

France
One World Cannabis Ltd.

Completed

A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

Safety Study for Future Treatment of Psoriasis

Israel
Macquarie University, Australia
ZZ Biotech, LLC

Completed

3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Australia
Karolinska Institutet
Rehband Sweden

Completed

Effects of Eccentric Training for Patients With Lateral Epicondylalgia

Tennis Elbow | Epicondylitis, Lateral Humeral

Sweden
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects. (OPS-2071Ph1)

Healthy

Korea, Republic of
Mackay Memorial Hospital
OBI Pharma, Inc

Unknown

Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

Ovarian Cancer

Taiwan
Otsuka Pharmaceutical Co., Ltd.

Completed

Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma

Hepatocellular Carcinoma

Japan
Nobelpharma

Completed

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Cytomegalovirus Disease

United States, Japan
Johns Hopkins Bloomberg School of Public Health
Makerere University; Pontificia Universidad Javeriana; The Bloomberg Family Foundation...

Completed

Use of Consent Language and Mode to Improve Interactive Voice Response Survey in Colombia and Uganda

Noncommunicable Diseases | Surveys and Questionnaires

Colombia, Uganda
Johns Hopkins University
Medical University of South Carolina; Vanderbilt University Medical Center; University... and other collaborators

Recruiting

Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System (NEWTON)

Pleural Effusion

United States, United Kingdom
University of Pennsylvania

Completed

SupportBP 2.0:Behavioral Science and Enrollment in Remote Monitoring for Hypertension Management

Hypertension

United States
Nobelpharma

Completed

An Additional Study of NPC-22 in Healthy Adult Males

Safety and Pharmacokinetics

Japan
Nobelpharma

Completed

A Study of NPC-22 in Healthy Adult Males

Healthy Adult Subjects

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects

Atopic Dermatitis

Japan
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Clinical Reminder Changes to Increase Smoking Cessation Treatment in Outpatient Psychiatry

Smoking Cessation

United States
University of Pennsylvania

Completed

Opt-In Versus Opt-Out for Colorectal Cancer Screening Outreach

Cancer of the Colon
Rigshospitalet, Denmark

Recruiting

Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.

COVID-19 | Influenza | RSV Infection

Denmark
Otsuka Pharmaceutical Co., Ltd.

Completed

Phase I Study of OPC-61815

Congestive Heart Failure

Japan
University of Pennsylvania
National Institute on Aging (NIA)

Completed

Hepatocellular Carcinoma Surveillance in Cirrhotics

Hepatocellular Carcinoma | Cirrhosis

United States
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China

Search clinical trials for: OPC-41061

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations